Challapudi Geetha, Natarajan Girija, Aggarwal Sanjeev
Division of Cardiology, Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Wayne State University School of Medicine, Detroit, Mich, USA.
Congenit Heart Dis. 2013 Nov-Dec;8(6):556-60. doi: 10.1111/chd.12048. Epub 2013 Mar 20.
A subset of children with repaired congenital heart disease (CHD) may require tracheostomy for ongoing ventilatory support. Data on outcomes of children with CHD and tracheostomy are scarce. Our objectives were to describe indications for tracheostomy and outcomes, including readmission data in this population.
This is a retrospective chart review of children (<18 years old) with CHD who underwent tracheostomy at a single center over a 12-year period. Exclusion criteria were prematurity with isolated patent ductus arteriosus ligation. Outcomes until discharge and data on all readmissions after the initial discharge were reviewed.
A total of 21 subjects with CHD underwent tracheostomy at a median (range) age of 4 (1-84) months and mean (standard deviation) weight of 7.2 (5.9) kg. The most common indication for tracheostomy was tracheomalacia with ventilator-dependent respiratory failure (14/21 subjects), followed by subglottic stenosis (5) and vocal cord palsy (2). Genetic syndromes were present in 13 (62%) subjects. The mean (standard deviation) post-tracheostomy length of stay was 55 (35) days. All subjects survived to discharge; 17 (81%) required home ventilation. A total of 11 (52%) subjects died during follow-up, all of whom were mechanically ventilated while three (14%) children underwent successful decannulation. The mean number of nonelective readmissions decreased from 2.4/patient-year in the first year to 1.4/patient-year in the second year, respectively. The commonest reasons for readmission were respiratory deterioration, infections, and mechanical tracheostomy-related problems.
The majority of children with CHD who underwent tracheostomy did so for ventilator dependence and tracheomalacia and had coexisting genetic syndromes. About half the cohort died; among survivors, readmissions were common but decreased after the first year. These results underscore the ongoing mortality and morbidity risks faced by this vulnerable population.
一部分接受过先天性心脏病(CHD)修复手术的儿童可能需要气管造口术以获得持续的通气支持。关于患有CHD且接受气管造口术儿童的预后数据较少。我们的目的是描述气管造口术的指征及预后情况,包括该人群的再入院数据。
这是一项对12年间在单一中心接受气管造口术的18岁以下CHD患儿进行的回顾性病历审查。排除标准为仅行动脉导管未闭结扎术的早产儿。对出院前的预后情况以及首次出院后所有再入院的数据进行了审查。
共有21例CHD患儿接受了气管造口术,中位(范围)年龄为4(1 - 84)个月,平均(标准差)体重为7.2(5.9)kg。气管造口术最常见的指征是气管软化伴呼吸机依赖型呼吸衰竭(14/21例患儿),其次是声门下狭窄(5例)和声带麻痹(2例)。13例(62%)患儿存在遗传综合征。气管造口术后平均(标准差)住院时间为55(35)天。所有患儿均存活至出院;17例(81%)需要家庭通气。共有11例(52%)患儿在随访期间死亡,所有死亡患儿均接受机械通气,3例(14%)患儿成功拔管。非选择性再入院的平均次数分别从第一年的2.4次/患者年降至第二年的1.4次/患者年。再入院最常见的原因是呼吸恶化、感染以及与气管造口术相关的机械问题。
大多数接受气管造口术的CHD患儿是因为呼吸机依赖和气管软化,且并存遗传综合征。约半数队列患儿死亡;在幸存者中,再入院情况常见,但在第一年之后有所减少。这些结果凸显了这一脆弱人群持续面临的死亡和发病风险。